Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Beximco Pharmaceuticals's
Operating Income
for the
three
months ended in Dec. 2024 was $20.54 Mil. Beximco Pharmaceuticals's Interest Expense for the
three
months ended in Dec. 2024 was $-1.70 Mil.
Beximco Pharmaceuticals's interest coverage for the quarter that ended in Dec. 2024 was 12.05.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Beximco Pharmaceuticals's Interest Coverage or its related term are showing as below:
BXMPY'
s Interest Coverage Range Over the Past 10 Years
Min: 3.29 Med: 5.97 Max: 8.26
Current: 8.77
BXMPY's Interest Coverage is not ranked
in the Drug Manufacturers industry.
Industry Median: 12.78
vs BXMPY: 8.77
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Beximco Pharmaceuticals Interest Coverage Related Terms
Beximco Pharmaceuticals Interest Coverage Historical Data
* Premium members only.
The historical data trend for Beximco Pharmaceuticals's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Drug Manufacturers - Specialty & Generic subindustry, Beximco Pharmaceuticals's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beximco Pharmaceuticals Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Beximco Pharmaceuticals's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Beximco Pharmaceuticals's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beximco Pharmaceuticals (BXMPY) has a Interest Coverage of 12.05 as of Dec. 2024. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Beximco Pharmaceuticals and its competitors. This is 102% above median its historical median of 5.97. Over the past decade, Beximco Pharmaceuticals' Interest Coverage has ranged from 3.29 to 8.26.
Is Beximco Pharmaceuticals' Interest Coverage too high?
Beximco Pharmaceuticals' current Interest Coverage of 12.05 is 102% above median its 10-year median of 5.97. Over the past 10 years, this metric has ranged from a low of 3.29 to a high of 8.26. The Drug Manufacturers industry median Interest Coverage is 12.78. Beximco Pharmaceuticals' value of 12.05 is 5.7% below this industry median. Overall, Beximco Pharmaceuticals has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does Beximco Pharmaceuticals' Interest Coverage compare to ZTS and UTHR?
Beximco Pharmaceuticals' Interest Coverage of 12.05 can be compared against companies in the Drug Manufacturers industry. The industry median Interest Coverage is 12.78. Beximco Pharmaceuticals' value of 12.05 is 5.7% below this benchmark. Historically, Beximco Pharmaceuticals' own Interest Coverage has ranged from 3.29 to 8.26 over the past decade. While the company's 10-year median is 5.97 vs. the industry median of 12.78, Beximco Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.78, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beximco Pharmaceuticals's current Interest Coverage of 12.05 is 5.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Beximco Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beximco Pharmaceuticals's current Interest Coverage is 12.05, which is 102% above median its own 10-year median of 5.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beximco Pharmaceuticals stock overvalued right now?
Beximco Pharmaceuticals (BXMPY) has a current Interest Coverage of 12.05. The current Interest Coverage is 12.05, which is 102% above median its 10-year median of 5.97 and 5.7% below the Drug Manufacturers industry median of 12.78. Beximco Pharmaceuticals' overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Beximco Pharmaceuticals (BXMPY), the current Interest Coverage is 12.05 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Beximco Pharmaceuticals PLC is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from domestic sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BXMPY has been successfully added to your 